FundedIQ
Climate Technology Product Manufact…

Hydryx

Hydryx helps decrease emissions, optimize the recovery of resources, and enables landfills to contribute to the transition to renewable energy.

www.hydryx.eu Amsterdam, The Netherlands 11-50 employees
Total raised
$2.9M
Rounds
1
Latest
Seed
Oct 2025

Hydryx helps decrease emissions, optimize the recovery of resources, and enables landfills to contribute to the transition to renewable energy.

Hydryx has raised $2.9M across 1 round. Its most recent round was a Seed of $2.9M in Oct 2025. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Oct 21, 2025
Seed
$2.9M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Hydryx is featured in

Similar companies

Enlite Research

Enlite has worked extensively to use IoT for delivering a comprehensive and holistic real estate solution called Know Your Building™. Know Your Building™ is a wireless building automation solution for commercial real estate. https://knowyourbuilding.com It is an interplay of Hardware & Software. Applications of this flexible and interoperable system go beyond a traditional BMS in the areas of real time Integration, monitoring & controlling

Series A $5.3M
Reaforma

Reaforma is reinventing the linear process of take, make, and waste and creating a circular solution.

Series Unknown $130k
Materials Nexus

Materials Nexus is an advanced technology firm that utilizes automation to enhance the precision of quantum calculations on a large scale. By doing so, the company expedites the transition towards eliminating materials that contribute to carbon emissions. Their primary focus is on speeding up the progress of material development while simultaneously reducing CO2e emissions.

Seed $2.6M
Ore Energy

Ore Energy develops long-duration energy storage systems for renewable energy applications and electric power grids.

Series A $43.0M
Yanara

Yanara is a renewable energy company that builds, owns, and operates utility scale hybrid power plants.

Series Unknown $171M
Tempress Systems

Tempress Systems, Inc. develops and manufactures horizontal and vertical diffusion/atmospheric and low pressure chemical vapor deposition

Private Equity $22.9M
Promptwatch

Get your brand mentioned by AI search engines.

Seed $6.8M
Nopan

Nopan is a specialized Payment Service Provider built to optimize European account-to-account and digital wallet payments.

Seed $8.2M
Aardaia

Aardaia is leading the way in a new era of domestication on demand.

Seed $5.7M
ProQR Therapeutics

ProQR Therapeutics is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313. Its product pipeline includes QRX-704, QRX-504, QRX-421, QRX-323 etc.

Series Unknown $59.2M
UniQure

uniQure is a leader in the field of gene therapy and had developed the first and currently the only gene therapy product to receive regulatory approval in the European Union. Gene therapy offers the prospect of long-term and potentially curative benefit to patients with genetic or acquired diseases by directing the expression of a therapeutic protein or restoring the expression of a missing protein through a single administration. Our first product, Glybera, was approved by the European Commission in October 2012 under exceptional circumstances for the treatment of a subset of patients with lipoprotein lipase deficiency, or LPLD, a potentially life-threatening, orphan metabolic disease. We are also developing a pipeline of additional adeno-associated virus (AAV)-based gene therapies through multiple collaborations. We develop our gene therapies using our innovative, modular technology platform, including our proprietary manufacturing process. We initially are focused on orphan diseases but believe that we will also be able to develop gene therapies targeting chronic and degenerative diseases that affect larger populations.

Series Unknown $259M
Droppie

Droppie is a recycling company that makes recycling easy and more accessible for consumers. The app is designed to help consumers recycle more effectively by offering small rewards for their recycled materials.

Seed $4.8M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.